FLASH Radiotherapy — The Ultra-High Dose Frontier
While still largely in the "Late-Stage Clinical Trial" phase in 2026, FLASH-RT represents the most radical shift in the field's history.
Ultra-High Dose Rates: FLASH delivers the entire course of radiation in less than one second—roughly 1,000 times faster than conventional therapy.
The "FLASH Effect": Biological studies show that at these extreme speeds, normal tissue seems to be "spared" from damage while the tumor is still effectively killed. This phenomenon is currently being tested in 2026 for deep-seated tumors in the thorax and abdomen.
Operational Shift: If successful, FLASH could turn a 6-week treatment course into a single, one-second visit, effectively ending the era of long-term fractionation for many patients.
1 View